nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—LHCGR—polycystic ovary syndrome	0.784	1	CbGaD
Goserelin—LHCGR—corpus luteum—polycystic ovary syndrome	0.0456	0.48	CbGeAlD
Goserelin—LHCGR—ovarian follicle—polycystic ovary syndrome	0.0356	0.376	CbGeAlD
Goserelin—Cetrorelix—LHCGR—polycystic ovary syndrome	0.00476	1	CrCbGaD
Goserelin—LHCGR—adipose tissue—polycystic ovary syndrome	0.00318	0.0335	CbGeAlD
Goserelin—LHCGR—female gonad—polycystic ovary syndrome	0.00266	0.028	CbGeAlD
Goserelin—LHCGR—endocrine gland—polycystic ovary syndrome	0.00247	0.0261	CbGeAlD
Goserelin—GNRHR—pituitary gland—polycystic ovary syndrome	0.00206	0.0217	CbGeAlD
Goserelin—GNRHR—female gonad—polycystic ovary syndrome	0.00171	0.0181	CbGeAlD
Goserelin—GNRHR—endocrine gland—polycystic ovary syndrome	0.00159	0.0168	CbGeAlD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1B—polycystic ovary syndrome	0.000452	0.00425	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.000443	0.00415	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.000431	0.00405	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.000426	0.004	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.000415	0.00389	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—ADRB2—polycystic ovary syndrome	0.000414	0.00388	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.000404	0.00379	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000392	0.00368	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—GNAS—polycystic ovary syndrome	0.000383	0.0036	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—ADRA1A—polycystic ovary syndrome	0.000383	0.0036	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.000381	0.00358	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.000379	0.00356	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.000379	0.00356	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.000379	0.00356	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.000376	0.00353	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.000365	0.00343	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000361	0.00339	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—GNRH1—polycystic ovary syndrome	0.000356	0.00334	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.000355	0.00333	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—ADRB2—polycystic ovary syndrome	0.000355	0.00333	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.000353	0.00331	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—NPB—polycystic ovary syndrome	0.000346	0.00325	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.000344	0.00323	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1A—polycystic ovary syndrome	0.000343	0.00322	CbGpPWpGaD
Goserelin—Renal impairment—Metformin—polycystic ovary syndrome	0.000337	0.033	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.000335	0.00314	CbGpPWpGaD
Goserelin—Lethargy—Metformin—polycystic ovary syndrome	0.000327	0.032	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000323	0.00303	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.000319	0.00299	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000316	0.00296	CbGpPWpGaD
Goserelin—Migraine—Metformin—polycystic ovary syndrome	0.000315	0.0309	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000292	0.00274	CbGpPWpGaD
Goserelin—Breast disorder—Metformin—polycystic ovary syndrome	0.000289	0.0284	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.000289	0.00271	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.000289	0.00271	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000289	0.00271	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000278	0.00261	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.000278	0.00261	CbGpPWpGaD
Goserelin—Influenza—Metformin—polycystic ovary syndrome	0.000277	0.0271	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000275	0.00258	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00027	0.00254	CbGpPWpGaD
Goserelin—Angina pectoris—Metformin—polycystic ovary syndrome	0.00027	0.0264	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000269	0.00252	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000265	0.00249	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000264	0.00248	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000262	0.00246	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000259	0.00243	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000259	0.00243	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.000258	0.00242	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000257	0.00242	CbGpPWpGaD
Goserelin—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000257	0.0252	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.000255	0.00239	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.000254	0.00238	CbGpPWpGaD
Goserelin—Drowsiness—Metformin—polycystic ovary syndrome	0.000247	0.0242	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000246	0.0023	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.000244	0.00229	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000244	0.00229	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000242	0.00227	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.000241	0.00226	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00024	0.00225	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000238	0.00224	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.000236	0.00222	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00023	0.00216	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000228	0.00214	CbGpPWpGaD
Goserelin—Rhinitis—Metformin—polycystic ovary syndrome	0.000222	0.0218	CcSEcCtD
Goserelin—Hepatitis—Metformin—polycystic ovary syndrome	0.000222	0.0217	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000221	0.00208	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000221	0.00208	CbGpPWpGaD
Goserelin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000218	0.0214	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000216	0.00203	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000215	0.00202	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.000215	0.00202	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000211	0.00198	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000207	0.00194	CbGpPWpGaD
Goserelin—Eye disorder—Metformin—polycystic ovary syndrome	0.000207	0.0203	CcSEcCtD
Goserelin—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000206	0.0202	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000201	0.00189	CbGpPWpGaD
Goserelin—Angiopathy—Metformin—polycystic ovary syndrome	0.000201	0.0197	CcSEcCtD
Goserelin—Immune system disorder—Metformin—polycystic ovary syndrome	0.0002	0.0196	CcSEcCtD
Goserelin—Chills—Metformin—polycystic ovary syndrome	0.000199	0.0195	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000197	0.00185	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000196	0.00184	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000196	0.00184	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000196	0.00184	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000193	0.00181	CbGpPWpGaD
Goserelin—Malnutrition—Metformin—polycystic ovary syndrome	0.000193	0.0189	CcSEcCtD
Goserelin—Erythema—Metformin—polycystic ovary syndrome	0.000193	0.0189	CcSEcCtD
Goserelin—Flatulence—Metformin—polycystic ovary syndrome	0.00019	0.0186	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000186	0.00175	CbGpPWpGaD
Goserelin—Muscle spasms—Metformin—polycystic ovary syndrome	0.000185	0.0182	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000184	0.00173	CbGpPWpGaD
Goserelin—Vision blurred—Metformin—polycystic ovary syndrome	0.000182	0.0178	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000181	0.0017	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00018	0.00169	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000179	0.00168	CbGpPWpGaD
Goserelin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000179	0.0175	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000178	0.00167	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000178	0.00167	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000178	0.00167	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000177	0.00166	CbGpPWpGaD
Goserelin—Malaise—Metformin—polycystic ovary syndrome	0.000174	0.017	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000173	0.00163	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000173	0.00163	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000172	0.00162	CbGpPWpGaD
Goserelin—Palpitations—Metformin—polycystic ovary syndrome	0.00017	0.0167	CcSEcCtD
Goserelin—Hypertension—Metformin—polycystic ovary syndrome	0.000167	0.0163	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000164	0.00154	CbGpPWpGaD
Goserelin—Myalgia—Metformin—polycystic ovary syndrome	0.000164	0.0161	CcSEcCtD
Goserelin—Chest pain—Metformin—polycystic ovary syndrome	0.000164	0.0161	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000163	0.00153	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000163	0.00153	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000163	0.00153	CbGpPWpGaD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000163	0.016	CcSEcCtD
Goserelin—Discomfort—Metformin—polycystic ovary syndrome	0.000162	0.0159	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000162	0.00152	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000161	0.00151	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000159	0.0015	CbGpPWpGaD
Goserelin—Oedema—Metformin—polycystic ovary syndrome	0.000157	0.0154	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000157	0.00147	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NPB—polycystic ovary syndrome	0.000157	0.00147	CbGpPWpGaD
Goserelin—Infection—Metformin—polycystic ovary syndrome	0.000156	0.0153	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000155	0.00146	CbGpPWpGaD
Goserelin—Shock—Metformin—polycystic ovary syndrome	0.000155	0.0152	CcSEcCtD
Goserelin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000154	0.0151	CcSEcCtD
Goserelin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000154	0.0151	CcSEcCtD
Goserelin—Skin disorder—Metformin—polycystic ovary syndrome	0.000153	0.015	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000153	0.00143	CbGpPWpGaD
Goserelin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000152	0.0149	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000152	0.00142	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00015	0.00141	CbGpPWpGaD
Goserelin—Anorexia—Metformin—polycystic ovary syndrome	0.00015	0.0147	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000148	0.00139	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000148	0.00139	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000148	0.00139	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000148	0.00139	CbGpPWpGaD
Goserelin—Hypotension—Metformin—polycystic ovary syndrome	0.000147	0.0144	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000145	0.00137	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000144	0.00135	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000143	0.0141	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000143	0.00134	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000142	0.00133	CbGpPWpGaD
Goserelin—Paraesthesia—Metformin—polycystic ovary syndrome	0.000141	0.0139	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000141	0.00132	CbGpPWpGaD
Goserelin—Dyspnoea—Metformin—polycystic ovary syndrome	0.00014	0.0138	CcSEcCtD
Goserelin—Somnolence—Metformin—polycystic ovary syndrome	0.00014	0.0137	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000139	0.00131	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000139	0.0013	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000139	0.0013	CbGpPWpGaD
Goserelin—Dyspepsia—Metformin—polycystic ovary syndrome	0.000139	0.0136	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000138	0.00129	CbGpPWpGaD
Goserelin—Decreased appetite—Metformin—polycystic ovary syndrome	0.000137	0.0134	CcSEcCtD
Goserelin—Fatigue—Metformin—polycystic ovary syndrome	0.000136	0.0133	CcSEcCtD
Goserelin—Constipation—Metformin—polycystic ovary syndrome	0.000135	0.0132	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000135	0.00126	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000132	0.00124	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000132	0.00124	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000131	0.00123	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000131	0.00123	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000131	0.00123	CbGpPWpGaD
Goserelin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00013	0.0127	CcSEcCtD
Goserelin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000129	0.0126	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000126	0.00118	CbGpPWpGaD
Goserelin—Urticaria—Metformin—polycystic ovary syndrome	0.000125	0.0123	CcSEcCtD
Goserelin—Abdominal pain—Metformin—polycystic ovary syndrome	0.000124	0.0122	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000123	0.00116	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000122	0.00115	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000121	0.00114	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00012	0.00113	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000119	0.00112	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000119	0.00112	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000119	0.00111	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000116	0.00108	CbGpPWpGaD
Goserelin—Asthenia—Metformin—polycystic ovary syndrome	0.000113	0.0111	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000113	0.00106	CbGpPWpGaD
Goserelin—Pruritus—Metformin—polycystic ovary syndrome	0.000111	0.0109	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000109	0.00103	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000108	0.00102	CbGpPWpGaD
Goserelin—Diarrhoea—Metformin—polycystic ovary syndrome	0.000108	0.0106	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000105	0.000987	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000105	0.000986	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NPB—polycystic ovary syndrome	0.000105	0.000985	CbGpPWpGaD
Goserelin—Dizziness—Metformin—polycystic ovary syndrome	0.000104	0.0102	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000104	0.000975	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000103	0.000962	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000102	0.000953	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000101	0.000943	CbGpPWpGaD
Goserelin—Vomiting—Metformin—polycystic ovary syndrome	0.0001	0.00981	CcSEcCtD
Goserelin—Rash—Metformin—polycystic ovary syndrome	9.93e-05	0.00973	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	9.92e-05	0.000931	CbGpPWpGaD
Goserelin—Dermatitis—Metformin—polycystic ovary syndrome	9.92e-05	0.00972	CcSEcCtD
Goserelin—Headache—Metformin—polycystic ovary syndrome	9.86e-05	0.00966	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—SCT—polycystic ovary syndrome	9.74e-05	0.000914	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FSHR—polycystic ovary syndrome	9.57e-05	0.000898	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—ADRB3—polycystic ovary syndrome	9.55e-05	0.000896	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	9.49e-05	0.00089	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—LHB—polycystic ovary syndrome	9.44e-05	0.000886	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—POMC—polycystic ovary syndrome	9.37e-05	0.00088	CbGpPWpGaD
Goserelin—Nausea—Metformin—polycystic ovary syndrome	9.35e-05	0.00916	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—GNAS—polycystic ovary syndrome	9.32e-05	0.000875	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—GHRL—polycystic ovary syndrome	9.31e-05	0.000874	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	9.29e-05	0.000872	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GNRH1—polycystic ovary syndrome	9.23e-05	0.000866	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	9e-05	0.000845	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—SCT—polycystic ovary syndrome	8.84e-05	0.00083	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	8.76e-05	0.000822	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTGER3—polycystic ovary syndrome	8.76e-05	0.000822	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LHCGR—polycystic ovary syndrome	8.76e-05	0.000822	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FST—polycystic ovary syndrome	8.53e-05	0.000801	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	8.49e-05	0.000796	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	8.44e-05	0.000792	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ADRB3—polycystic ovary syndrome	8.43e-05	0.000791	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LHB—polycystic ovary syndrome	8.33e-05	0.000782	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	8.24e-05	0.000773	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTAFR—polycystic ovary syndrome	8.19e-05	0.000769	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GNRH1—polycystic ovary syndrome	8.14e-05	0.000764	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ADRA1D—polycystic ovary syndrome	7.95e-05	0.000746	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	7.88e-05	0.00074	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—GNAS—polycystic ovary syndrome	7.87e-05	0.000738	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SCT—polycystic ovary syndrome	7.8e-05	0.000732	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ADRA1B—polycystic ovary syndrome	7.73e-05	0.000726	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—ADRB2—polycystic ovary syndrome	7.71e-05	0.000723	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—INHBB—polycystic ovary syndrome	7.54e-05	0.000707	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	7.45e-05	0.000699	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FGF18—polycystic ovary syndrome	7.32e-05	0.000687	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RBP4—polycystic ovary syndrome	7.26e-05	0.000681	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—GNAS—polycystic ovary syndrome	7.14e-05	0.00067	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PDE3B—polycystic ovary syndrome	7.04e-05	0.00066	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6.86e-05	0.000644	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—YAP1—polycystic ovary syndrome	6.77e-05	0.000636	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GAB1—polycystic ovary syndrome	6.68e-05	0.000627	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FSHR—polycystic ovary syndrome	6.41e-05	0.000601	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—INSR—polycystic ovary syndrome	6.39e-05	0.000599	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—POMC—polycystic ovary syndrome	6.28e-05	0.000589	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GHRL—polycystic ovary syndrome	6.23e-05	0.000585	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	6.07e-05	0.00057	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	6.03e-05	0.000565	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	5.98e-05	0.000561	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PGR—polycystic ovary syndrome	5.91e-05	0.000555	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.86e-05	0.00055	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FST—polycystic ovary syndrome	5.71e-05	0.000536	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	5.68e-05	0.000533	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.64e-05	0.00053	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LHB—polycystic ovary syndrome	5.58e-05	0.000523	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GHRL—polycystic ovary syndrome	5.5e-05	0.000516	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PLAT—polycystic ovary syndrome	5.5e-05	0.000516	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.45e-05	0.000511	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—POMC—polycystic ovary syndrome	5.3e-05	0.000497	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.28e-05	0.000495	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GNAS—polycystic ovary syndrome	5.27e-05	0.000494	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ATF1—polycystic ovary syndrome	5.25e-05	0.000492	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SCT—polycystic ovary syndrome	5.22e-05	0.00049	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—ADRB2—polycystic ovary syndrome	5.16e-05	0.000484	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.12e-05	0.00048	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.09e-05	0.000478	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.98e-05	0.000468	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FGF18—polycystic ovary syndrome	4.9e-05	0.00046	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RBP4—polycystic ovary syndrome	4.86e-05	0.000456	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NGFR—polycystic ovary syndrome	4.84e-05	0.000454	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	4.84e-05	0.000454	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—POMC—polycystic ovary syndrome	4.81e-05	0.000451	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRL—polycystic ovary syndrome	4.8e-05	0.00045	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.78e-05	0.000449	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.62e-05	0.000434	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.55e-05	0.000427	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—YAP1—polycystic ovary syndrome	4.53e-05	0.000426	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GAB1—polycystic ovary syndrome	4.47e-05	0.00042	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—INSR—polycystic ovary syndrome	4.28e-05	0.000401	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GNAS—polycystic ovary syndrome	4.22e-05	0.000396	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.06e-05	0.000381	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.02e-05	0.000377	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	4e-05	0.000375	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PGR—polycystic ovary syndrome	3.96e-05	0.000372	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NRG1—polycystic ovary syndrome	3.95e-05	0.00037	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PLAT—polycystic ovary syndrome	3.68e-05	0.000345	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GHRL—polycystic ovary syndrome	3.68e-05	0.000345	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.55e-05	0.000333	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ATF1—polycystic ovary syndrome	3.51e-05	0.00033	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.42e-05	0.000321	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.41e-05	0.00032	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IRS2—polycystic ovary syndrome	3.38e-05	0.000317	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LEP—polycystic ovary syndrome	3.31e-05	0.00031	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NGFR—polycystic ovary syndrome	3.24e-05	0.000304	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—POMC—polycystic ovary syndrome	3.22e-05	0.000302	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRL—polycystic ovary syndrome	3.21e-05	0.000301	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.1e-05	0.00029	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.05e-05	0.000286	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IRS1—polycystic ovary syndrome	2.95e-05	0.000277	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—POMC—polycystic ovary syndrome	2.84e-05	0.000267	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—INS—polycystic ovary syndrome	2.83e-05	0.000265	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GNAS—polycystic ovary syndrome	2.83e-05	0.000265	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IGF1—polycystic ovary syndrome	2.73e-05	0.000257	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT2—polycystic ovary syndrome	2.73e-05	0.000256	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.69e-05	0.000253	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NRG1—polycystic ovary syndrome	2.64e-05	0.000248	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.6e-05	0.000244	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IRS2—polycystic ovary syndrome	2.26e-05	0.000212	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LEP—polycystic ovary syndrome	2.21e-05	0.000208	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—polycystic ovary syndrome	2.09e-05	0.000196	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IRS1—polycystic ovary syndrome	1.98e-05	0.000185	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—POMC—polycystic ovary syndrome	1.9e-05	0.000179	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—INS—polycystic ovary syndrome	1.89e-05	0.000178	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF1—polycystic ovary syndrome	1.83e-05	0.000172	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT2—polycystic ovary syndrome	1.83e-05	0.000172	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.79e-05	0.000168	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.74e-05	0.000163	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—polycystic ovary syndrome	1.4e-05	0.000131	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—polycystic ovary syndrome	1.23e-05	0.000116	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.2e-05	0.000112	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—polycystic ovary syndrome	8.27e-06	7.76e-05	CbGpPWpGaD
